Request Sample

UAE, with one of the highest rates of Type 2 diabetes represents significant societal costs, in relation to morbidity, mortality and also lost productivity coupled with a huge burden on the healthcare system. It has been observed that the high prevalence of diabetes in the UAE is gradually taking its toll on the overall health of the nation and also risking the country’s economic well-being.

The total number of diabetes patients in UAE were e estimated around 0.75 Million in 2013. With factors such as obesity, rising sedentary lifestyles and unhealthy diet acting in full force, it is expected that the number of diabetic patients in the UAE would grow at a CAGR of 4%-6%, which is double the growth rate of the global market. The number of diabetics in the UAE is expected to surpass 0.85 million by 2018.

The production of diabetes devices is not significant in the UAE. Only basic items such as syringes are manufactured in the UAE. Though the government is encouraging private entities and other public companies to increase the local domestic production sector, but the major hurdle is that UAE is not well equipped and does not posses the required capability to produce any high-tech equipment. The country is thus a net importer of devices used for diabetes care.

“UAE Diabetes Market Opportunity Analysis 2018” gives comprehensive insight on following aspects related to pharmaceutical market:

• Market Ove

1. UAE Diabetes Market Overview
1.1 Market Overview
1.2 Diabetes Incidence

2. UAE Diabetes Market Dynamics
2.1 Market Drivers
2.2 Challenges to be Resolved
2.3 Future Opportunities

3. UAE Diabetes Drug Market
3.1 Oral
3.2 Insulin

4. UAE Insulin Delivery Devices Market
4.1 Pens
4.2 Syringes

5. UAE Glucose Monitoring Devices Market

6. Competitive Market
6.1 Gulf Pharmaceutical Industries (Julphar Diabetes)
6.2 Eli Lilly
6.3 Novo Nordisk
6.4 Medysinal Fze
6.5 Sanofi-Aventis

List of Figures

Figure 1-1: Total Medical Cost for All Types of Diabetes (US$ Million), 2012-2018
Figure 1-2: Medical Cost for Type 2 Diabetes (US$ Million), 2012-2018
Figure 1-3: Medical Cost for Type-1 Diabetes (US$ Million), 2012-2018
Figure 1-4: Medical Cost for Undiagnosed Diabetes (US$ Million), 2012-2018
Figure 1-5: Diabetes Prevalence (%), 2012 & 2030
Figure 1-6: UAE v/s GCC Countries Diabetes Prevalence, 2012
Figure 1-7: Number of Type 2 Diabetes Cases (‘000), 2012-2018
Figure 1-8: Number of Type 1 Diabetes Cases (‘000), 2012-2018
Figure 1-9: Number of Undiagnosed Diabetes Cases (‘000), 2012-2018
Figure 1-10: Type-2 Diabetes Prevalence in Age Group 20-79 (%)
Figure 2-1: Factor Driving Diabetes Prevalence
Figure 2-2: Challenges for Diabetes Market
Figure 3-1: Oral Insulin Market (US$ Million), 2012-2018
Figure 3-2: Insulin Device (US$ Million), 2012-2018
Figure 4-1: Insulin Pen Market (US$ Million), 2012-2018
Figure 4-2: Insulin Syringe Market (US$ Million), 2012-2018
Figure 5-1: Glucose Monitoring Devices Market (US$ Million), 2012-2018

Saudi Arabia Infrastructure Report
BMI View: We significantly downgraded our short-term outlook for the Saudi Arabian construction sector on the back of liquidity in the market severely drying up, following a reduction in government spending. Beyond 2016 the goals of Vision 2030 will be key to opening up the infrastructure market with the potential of private investment
Saudi Arabia Insurance Report
BMI View: Within the non-life segment, growth in premiums through the forecast period will continue to bedriven by developments in two sub-sectors. There should be higher volumes (if not prices) in the motorvehicle insurance sub-sector, thanks to the expansion in the number of vehicles on Saudi Arabia's vehicles.Higher volumes and inflation in heal
Saudi Arabia: Operators Will Focus on Mobile Network Enhancements and Enterprises to Drive Growth
The telecommunications market in Saudi Arabia generated US$18.8bn in service revenue in 2016, an increase over 2015. Mobile data will emerge as the largest revenue-contributing segment by 2020. Over the next five years, operators can benefit from the opportunities existing in offering enterprise services, VoIP and mobile data. Operators are investi
Saudi Arabia Pharmaceuticals and Healthcare Report
BMI View: The combined value of Saudi Arabia's pharmaceutical and healthcare markets is the largest in the Middle East and Africa region. The Kingdom's National Transformation Program, a key part of Vision 2030, reinstates the government's commitment to improving healthcare provision in the country. Nonetheless, the rising burden of non
Saudi Arabia Petrochemicals Report
The Saudi government is targeting national petrochemicals output of 115mn tonnes in 2016, which represents a 46% increase since 2013. There are 26 petrochemicals projects under construction at a cost of USD15bn while another 42 are planned over the next five years at an estimated cost of USD46bn. However, there is the ongoing threat fro

If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice.
Please visit Custom Research page to make an enquiry.

Custom Research

Contact Us

808, Real Tech Park, 8th Floor, Sector 30A, Vashi, Navi Mumbai - 400703 , INDIA .

+91 22 27810772, 27810773